Answers are grounded in this paper and cite their sources.
This review reveals the role of hif-1 alpha in therapeutic angiogenesis for ischemic cardiovascular disease, highlighting both oxygen-dependent and independent mechanisms.
Hypoxia, or lack of adequate oxygen saturation, activates a vast repertoire of vascular responses to increase cell survival and proliferation, driven primarily by activation of oxygen-sensing hypoxia-inducible factors (HIFs). Key hypoxia mediator HIF-1 alpha is capable of driving vascular restructuring in response to low oxygen tension and oxygen-independent signaling pathways, and thus serves as a promising therapeutic modulator for ischemic cardiovascular diseases such as peripheral artery disease and coronary artery disease. In this review, we discuss oxygen-dependent and oxygen-independent mechanisms of HIF-1 alpha regulation, the HIF protein family’s role in vessel collateralization, and translational efforts seeking to exploit HIF-1 alpha’s key role in hypoxia signaling for the purpose of therapeutic development of clinical treatments for ischemic cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Carmichael et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: